Similar articles for PMID: 28486922

Year	Number of Results
2007	3
2009	2
2010	6
2011	5
2012	8
2013	11
2014	10
2015	15
2016	23
2017	26
2018	24
2019	24
2020	22
2021	20
2022	18
2023	7
2024	1

1

An Overview on Screening Methods for Lysine Specific Demethylase 1 (LSD1) Inhibitors.

Zheng YC, Chang J, Zhang T, Suo FZ, Chen XB, Liu Y, Zhao B, Yu B, Liu HM. Zheng YC, et al. Curr Med Chem. 2017;24(23):2496-2504. doi: 10.2174/0929867324666170509114321. Curr Med Chem. 2017. PMID: 28486922 Review.

2

LSD1 Histone Demethylase Assays and Inhibition.

Hayward D, Cole PA. Hayward D, et al. Methods Enzymol. 2016;573:261-78. doi: 10.1016/bs.mie.2016.01.020. Epub 2016 Feb 23. Methods Enzymol. 2016. PMID: 27372757 Free PMC article. Review.

3

Identification of Novel Selective Lysine-Specific Demethylase 1 (LSD1) Inhibitors Using a Pharmacophore-Based Virtual Screening Combined with Docking.

Zhou C, Kang D, Xu Y, Zhang L, Zha X. Zhou C, et al. Chem Biol Drug Des. 2015 Jun;85(6):659-71. doi: 10.1111/cbdd.12461. Epub 2014 Dec 22. Chem Biol Drug Des. 2015. PMID: 25346381

4

Histone H3 peptide based LSD1-selective inhibitors.

Kakizawa T, Ota Y, Itoh Y, Tsumoto H, Suzuki T. Kakizawa T, et al. Bioorg Med Chem Lett. 2015 May 1;25(9):1925-8. doi: 10.1016/j.bmcl.2015.03.030. Epub 2015 Mar 20. Bioorg Med Chem Lett. 2015. PMID: 25827526

5

Structure-based design and discovery of potent and selective lysine-specific demethylase 1 (LSD1) inhibitors.

Nie Z, Shi L, Lai C, Severin C, Xu J, Del Rosario JR, Stansfield RK, Cho RW, Kanouni T, Veal JM, Stafford JA, Chen YK. Nie Z, et al. Bioorg Med Chem Lett. 2019 Jan 1;29(1):103-106. doi: 10.1016/j.bmcl.2018.11.001. Epub 2018 Nov 3. Bioorg Med Chem Lett. 2019. PMID: 30409536

6

Machine-Learning-Enabled Virtual Screening for Inhibitors of Lysine-Specific Histone Demethylase 1.

Zhou J, Wu S, Lee BG, Chen T, He Z, Lei Y, Tang B, Hirst JD. Zhou J, et al. Molecules. 2021 Dec 10;26(24):7492. doi: 10.3390/molecules26247492. Molecules. 2021. PMID: 34946572 Free PMC article.

7

Histone H3 peptides incorporating modified lysine residues as lysine-specific demethylase 1 inhibitors.

Kakizawa T, Ota Y, Itoh Y, Suzuki T. Kakizawa T, et al. Bioorg Med Chem Lett. 2018 Jan 15;28(2):167-169. doi: 10.1016/j.bmcl.2017.11.035. Epub 2017 Nov 23. Bioorg Med Chem Lett. 2018. PMID: 29198865

8

Medicinal chemistry insights in the discovery of novel LSD1 inhibitors.

Wang X, Huang B, Suzuki T, Liu X, Zhan P. Wang X, et al. Epigenomics. 2015;7(8):1379-96. doi: 10.2217/epi.15.86. Epub 2015 Dec 8. Epigenomics. 2015. PMID: 26646727 Review.

9

Drug Design Concepts for LSD1-Selective Inhibitors.

Ota Y, Suzuki T. Ota Y, et al. Chem Rec. 2018 Dec;18(12):1782-1791. doi: 10.1002/tcr.201810031. Epub 2018 Sep 11. Chem Rec. 2018. PMID: 30277644 Review.

10

Design, Synthesis, and In Vitro Evaluation of Novel Histone H3 Peptide-Based LSD1 Inactivators Incorporating α,α-Disubstituted Amino Acids with γ-Turn-Inducing Structures.

Ota Y, Kakizawa T, Itoh Y, Suzuki T. Ota Y, et al. Molecules. 2018 May 6;23(5):1099. doi: 10.3390/molecules23051099. Molecules. 2018. PMID: 29734782 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

190 results

Results by year